EP300 and prostate cancer: Consistently, in CRISPR-based dependency maps (DepMap), p300 ranks as the most essential histone acetyltransferase in AR-driven prostate cancer cells, implying a pivotal role of p300/H2BNTac on prostate cancer cell viability.